<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03628183</url>
  </required_header>
  <id_info>
    <org_study_id>AL30</org_study_id>
    <nct_id>NCT03628183</nct_id>
  </id_info>
  <brief_title>Tolerance of Infants Fed a Hydrolysate Formula</brief_title>
  <official_title>Tolerance of Infants Fed a Hydrolysate Formula Manufactured With a New Processing Method</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Nutrition</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Nutrition</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, randomized, multicenter study to assess the tolerance of infant&#xD;
      formulas.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 28, 2018</start_date>
  <completion_date type="Actual">November 23, 2018</completion_date>
  <primary_completion_date type="Actual">November 23, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Stool Characteristics</measure>
    <time_frame>Study Day 1 - Study Day 21</time_frame>
    <description>Parent completed diary</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Formula Intake</measure>
    <time_frame>Study Day 1 - Study Day 21</time_frame>
    <description>Parent completed diary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight</measure>
    <time_frame>Study Day 1 - Study Day 21</time_frame>
    <description>Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length</measure>
    <time_frame>Study Day 1 - Study Day 21</time_frame>
    <description>Length board</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Gastrointestinal Tolerance</condition>
  <arm_group>
    <arm_group_label>Hydrolysate Infant Formula 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ready to feed infant formula in can</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hydrolysate Infant Formula 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ready to feed infant formula in bottle</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hydrolysate Infant Formula 1</intervention_name>
    <description>Feed ad lib</description>
    <arm_group_label>Hydrolysate Infant Formula 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hydrolysate Infant Formula 2</intervention_name>
    <description>Feed ad lib</description>
    <arm_group_label>Hydrolysate Infant Formula 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject is judged to be in good health&#xD;
&#xD;
          -  Singleton from a full-term birth&#xD;
&#xD;
          -  Birth weight was &gt; or = to 2490 g&#xD;
&#xD;
          -  Between 0 and 14 days of age at enrollment&#xD;
&#xD;
          -  Parent(s) confirm their intention to feed their infant the assigned study product as&#xD;
             the sole source of nutrition for the duration of the study&#xD;
&#xD;
          -  Parent(s) confirm their intention not to administer vitamin or mineral supplements,&#xD;
             solid foods or juices to their infant from enrollment through the duration of the&#xD;
             study&#xD;
&#xD;
          -  Subject's parent(s) has voluntarily signed and dated an Informed Consent Form (ICF)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  An adverse maternal, fetal or subject medical history that is thought by the&#xD;
             investigator to have potential for effects on tolerance, growth, and/or development.&#xD;
&#xD;
          -  Subject is taking and plans to continue medications, home remedies, herbal&#xD;
             preparations or rehydration fluids that might affect gastrointestinal (GI) tolerance&#xD;
&#xD;
          -  Subject participates in another study that has not been approved as a concomitant&#xD;
             study&#xD;
&#xD;
          -  Subject has an allergy or intolerance to any ingredient in the study product&#xD;
&#xD;
          -  Subject has been treated with antibiotics within 2 weeks prior to enrollment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>14 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Courtney Allgeier, MS, RD, LD</last_name>
    <role>Study Chair</role>
    <affiliation>Abbott Nutrition</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Watching Over Mothers and Babies</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85712</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Springs Medical Research</name>
      <address>
        <city>Owensboro</city>
        <state>Kentucky</state>
        <zip>42303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Cleveland Pediatric Research Center, LLC</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44130</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute of Clinical Research, LLC</name>
      <address>
        <city>Mentor</city>
        <state>Ohio</state>
        <zip>44060</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Midsouth Center for Clinical Research</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38116</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2018</verification_date>
  <study_first_submitted>July 13, 2018</study_first_submitted>
  <study_first_submitted_qc>August 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 14, 2018</study_first_posted>
  <last_update_submitted>December 17, 2018</last_update_submitted>
  <last_update_submitted_qc>December 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

